X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (123) 123
humans (114) 114
middle aged (95) 95
life sciences (93) 93
female (91) 91
male (88) 88
adult (83) 83
cancer (79) 79
aged (74) 74
hematology (70) 70
oncology (59) 59
chemotherapy (54) 54
lymphomas (54) 54
adolescent (37) 37
lymphoma (37) 37
treatment outcome (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
aged, 80 and over (31) 31
prognosis (31) 31
rituximab (31) 31
disease-free survival (30) 30
young adult (27) 27
abridged index medicus (26) 26
survival analysis (24) 24
therapy (24) 24
disease (23) 23
survival (23) 23
antineoplastic combined chemotherapy protocols - administration & dosage (22) 22
analysis (21) 21
non-hodgkins-lymphoma (21) 21
positron-emission-tomography (20) 20
survival rate (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
doxorubicin - administration & dosage (18) 18
hodgkin disease - drug therapy (18) 18
transplantation (18) 18
follow-up studies (17) 17
prospective studies (17) 17
risk factors (17) 17
trial (17) 17
cyclophosphamide - administration & dosage (16) 16
hodgkin lymphoma (16) 16
care and treatment (15) 15
lymphoma, large b-cell, diffuse - drug therapy (15) 15
patients (15) 15
retrospective studies (15) 15
antineoplastic agents - therapeutic use (14) 14
cyclophosphamide (14) 14
medicine & public health (14) 14
neoplasm staging (14) 14
prednisone - administration & dosage (14) 14
vincristine - administration & dosage (14) 14
tumors (13) 13
b-cell lymphoma (12) 12
fluorodeoxyglucose f18 (12) 12
hodgkin's disease (12) 12
stem cells (12) 12
antibodies, monoclonal, murine-derived - administration & dosage (11) 11
cytarabine - administration & dosage (11) 11
doxorubicin - therapeutic use (11) 11
fdg-pet (11) 11
nuclear medicine (11) 11
radiotherapy (11) 11
autografts (10) 10
drug therapy (10) 10
hodgkin disease - mortality (10) 10
human health and pathology (10) 10
lymphoma, large b-cell, diffuse - mortality (10) 10
medical research (10) 10
medicine, general & internal (10) 10
positron-emission tomography (10) 10
proportional hazards models (10) 10
radiology, nuclear medicine & medical imaging (10) 10
risk (10) 10
tomography (10) 10
vincristine (10) 10
antibodies, monoclonal, murine-derived - therapeutic use (9) 9
clinical trials (9) 9
combined modality therapy (9) 9
cyclophosphamide - therapeutic use (9) 9
drug administration schedule (9) 9
elderly-patients (9) 9
hodgkin disease - pathology (9) 9
hodgkin disease - therapy (9) 9
immunology (9) 9
lymphocytes b (9) 9
mantle cell lymphoma (9) 9
positron emission tomography (9) 9
prednisone (9) 9
prednisone - therapeutic use (9) 9
rituximab - administration & dosage (9) 9
studies (9) 9
toxicity (9) 9
[ sdv.can ] life sciences [q-bio]/cancer (8) 8
abvd (8) 8
bleomycin - administration & dosage (8) 8
diagnosis (8) 8
doxorubicin (8) 8
hemic and lymphatic diseases (8) 8
immunotherapy (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 10, pp. 934 - 947
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 07/2011, Volume 118, Issue 1, pp. 37 - 43
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESPONSE CRITERIA | AGGRESSIVE LYMPHOMAS | POOR-PROGNOSIS | NON-HODGKINS-LYMPHOMA | REGIMEN | YOUNG-PATIENTS | ELDERLY-PATIENTS | DES-LYMPHOMES | TRANSPLANTATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Index Medicus | Abridged Index Medicus | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
Journal Article